7-OH-DPAT

7-OH-DPAT, or 7-hydroxy-N,N-dipropyl-2-aminotetralin, is a synthetic compound that acts as a selective agonist for the dopamine D3 receptor. It is a member of the aminotetralin class of compounds and is primarily used in scientific research to study the role of dopamine receptors in the brain.
Chemical Properties[edit]
7-OH-DPAT is characterized by its chemical structure, which includes a tetralin ring system with a hydroxyl group at the 7-position and two propyl groups attached to the nitrogen atom. This structure is crucial for its activity as a dopamine receptor agonist.
Pharmacology[edit]
7-OH-DPAT is known for its high affinity and selectivity for the dopamine D3 receptor, although it also has some activity at the dopamine D2 receptor. Its selectivity makes it a valuable tool in research for distinguishing the roles of different dopamine receptor subtypes in various physiological and pathological processes.
Mechanism of Action[edit]
As a dopamine receptor agonist, 7-OH-DPAT mimics the action of the neurotransmitter dopamine by binding to and activating dopamine receptors. This activation can influence numerous neurological processes, including motor control, reward, and cognition.
Research Applications[edit]
7-OH-DPAT is used extensively in preclinical studies to investigate the function of dopamine receptors in the brain. It has been employed in studies of Parkinson's disease, schizophrenia, and addiction, among other conditions. By selectively targeting the D3 receptor, researchers can better understand its specific contributions to these disorders.
Related Compounds[edit]
7-OH-DPAT is related to other aminotetralin compounds, such as 8-OH-DPAT, which is a selective agonist for the 5-HT1A receptor. These compounds are often used in tandem to explore the interactions between different neurotransmitter systems.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian